Business Profile & Competitive Position
Nordson Corporation operates in the Industrials sector under the Industrial - Machinery classification, but its business is best described as precision technology rather than heavy equipment. The company engineers, manufactures and markets differentiated products and systems that dispense, apply and control adhesives, coatings, polymers, sealants, biomaterials and other fluids. It also tests and inspects for quality, treats and cures surfaces, and produces medical products such as catheters, cannulas, medical balloons and tubing. Revenue is organized around three operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. Distribution is primarily through a direct sales force plus qualified distributors and sales representatives.
The financial metrics in the current snapshot support the idea that this is a margin-rich, asset-efficient franchise. Net margin is 18.6% and return on equity is 17.6%, both well above the typical range for diversified industrial machinery and consistent with a business whose products are embedded in customer production lines and supported by consumables, service and application expertise. A beta of 0.96 sits almost exactly in line with the broad market, suggesting the stock does not carry pronounced defensive or cyclical leverage relative to the S&P 500.
Financial Posture
Nordson’s market capitalization stands at $17.9 billion and the shares trade at a trailing P/E of 32.4 as of the latest snapshot, with the stock at $321.72. That valuation multiple is a clear premium to the broader industrial machinery group, which means the market is pricing in above-average growth, margin resilience or both. The 18.6% net margin and 17.6% ROE provide some justification for that premium, because they point to pricing power, high incremental returns and relatively low capital intensity for a manufacturing business.
On a technical snapshot, the 50-day exponential moving average is $306.63, so the current price sits roughly 4.9% above that short-to-intermediate trend measure, while the RSI at 56.9 is neutral rather than overbought. The existing data set does not include a debt or leverage figure, so any balance-sheet assessment should be based on the company’s filings rather than inferred from these headline numbers.
Strategic Priorities & Outlook
Nordson’s most recent 10-K frames the company’s direction around the Ascend strategy, launched in 2021, which is designed to deliver top-tier revenue growth with leading margins and returns. The strategy rests on three pillars: the NBS Next growth framework, an Owner Mindset division-led structure, and the Winning Teams talent strategy.
Operationally, management is using NBS Next to apply data-based segmentation that identifies the most attractive opportunities for profitable growth and directs investment accordingly. Organic growth levers include continually introducing new products and technology, providing high levels of customer service and support, capturing opportunities in emerging geographies, and applying existing technology to new applications. On the inorganic side, the company is pursuing acquisitions of precision-technology businesses with differentiated product portfolios, attractive high-growth end markets and customer-centric models that can complement capabilities, diversify end markets and broaden the solutions offered.
The 10-K also emphasizes the global scale of operations: direct operations in more than 35 countries, approximately 67% of 2025 revenues generated outside the United States, and no single customer accounting for 10% or more of sales. As of October 31, 2025, Nordson had roughly 8,000 employees worldwide, with principal manufacturing facilities in the United States, the People’s Republic of China, Bulgaria, Germany, Ireland, Israel, Italy, Mexico, the Netherlands and the United Kingdom. Management notes that the global supply chain has stabilized, lead times have improved and inflation risk has moderated, while caution remains around ongoing volatility in Asia-origin shipments and moderate rate increases in parcel and domestic trucking.
Macro & Geopolitical Exposure
Because Nordson sits in the Industrial - Machinery industry and sells precision systems to factories, medical-device makers and electronics assemblers, its fortunes are tied to global industrial capital spending and manufacturing activity. When customers delay capex, demand for dispensing, coating, curing and test systems typically softens; when capacity expands, order flow improves.
With approximately 67% of 2025 revenue generated outside the United States, the company is exposed to currency translation and cross-border trade policy. Tariffs, regional trade agreements and geopolitical tensions can affect both the cost of imported components and the competitiveness of exported systems. The 10-K specifically flags Asia-origin shipment volatility, so supply-chain disruptions or logistical bottlenecks in that region are relevant transmission channels. In addition, medical and biomaterials operations carry regulatory exposure tied to device approvals, quality standards and material safety rules across multiple jurisdictions. Freight, parcel and domestic trucking rates are also operational sensitivities that can move margins.
Recent Developments
On August 31, 2026, Zacks published Nordson Rewards Investors With 15% Dividend Hike on Strong Cash Flow, a capital-allocation signal that management is confident enough in cash generation to return more to shareholders. The same day, Zacks also ran a relative-value comparison titled MWA vs. NDSN: Which Stock Is the Better Value Option?, and 247WallSt.com published 3 Dividend Stocks with Unbelievable Streaks but Barely Pay Investors, indicating that Nordson is being discussed in the context of long dividend track records rather than high current yields. On August 30, 2026, Seeking Alpha’s Dividend Announcements: August 22-28, 2026 rounded up the recent distribution news. These headlines are consistent with a quality-industrial narrative rather than a turnaround or deep-value story.
Earnings Behavior & Post-Earnings Drift
Over the last eight reported quarters, Nordson has beaten earnings estimates six times, for a beat rate of 86%, with an average earnings surprise of 2.7%. Across those quarters, the average 5-day price move in the five trading days after the report is 2.55%, and the drift direction is classified as “up.” These figures imply that, on average, the market’s real expectation is modestly exceeded and the stock tends to carry positive momentum post-report.
The most recent four quarters show both the strength and the variability of that pattern. The August 19, 2026 report delivered actual EPS of $3.25 against an estimate of $3.09, a 5.2% surprise; the stock rose 8.0% the next day and 7.96% over the following five days. The May 20, 2026 quarter produced $2.86 versus $2.82, a 1.4% beat, with follow-through of +3.83% next-day and +4.32% over five days. The February 18, 2026 quarter came in exactly inline at $2.37 versus $2.37; the market’s reaction was negative, with the stock dropping 1.79% the next day and 2.83% over the subsequent five sessions. The December 10, 2025 quarter posted $3.03 versus $2.93, a 3.4% surprise, yet the stock slipped 0.8% the next day before recovering to +0.74% over five days. The next report is scheduled for December 9, 2026 after the close, with the current consensus EPS estimate at $3.45.
Frequently Asked Questions
What does Nordson primarily sell?
Nordson is a precision-technology company. Its systems dispense, apply and control adhesives, coatings, polymers, sealants and biomaterials; test and inspect for quality; treat and cure surfaces; and produce medical devices such as catheters and tubing. It reports through Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions.
How has the stock typically reacted to earnings reports?
Over the past eight quarters Nordson has beaten estimates 86% of the time, with an average surprise of 2.7% and an average 5-day post-earnings gain of 2.55%. However, individual reactions vary—the February 2026 inline result pushed the stock down 1.79% the next day.
What are the main macro risks for a business like Nordson?
Because it is classified in Industrial - Machinery and derives about 67% of revenue outside the United States, Nordson is exposed to global manufacturing capex cycles, currency translation, trade policy and tariffs, as well as supply-chain volatility—particularly Asia-origin shipments—and freight/logistics costs.
For a deeper dive into how sell-side and quantitative models currently view the institutional verdict on NDSN—including valuation, forward estimates and relative-rank within Industrial Machinery—readers should consult the full analyst consensus and institutional research page rather than relying on headline numbers alone.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-19 | $3.25 | $3.09 | +5.2% | +8% | +7.96% |
| 2026-05-20 | $2.86 | $2.82 | +1.4% | +3.83% | +4.32% |
| 2026-02-18 | $2.37 | $2.37 | 0% | -1.79% | -2.83% |
| 2025-12-10 | $3.03 | $2.93 | +3.4% | -0.8% | +0.74% |
| 2025-08-20 | $2.73 | $2.64 | +3.4% | - | - |
| 2025-05-28 | $2.42 | $2.36 | +2.5% | - | - |
Previous NDSN editions
Get the institutional verdict on NDSN
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the NDSN verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.